Diabetes & Obesity Podcasts: Obesity Drugs and Co-Morbidities

Published on: 

Diabetes & Obesity Series

Obesity Drugs and Co-Morbidities

Subscribe to RSS feed of this series


Dr. Richard Gregg
Chief Scientific Officer
Vitae Pharmaceuticals

Dr. Gregg offers insight into the development of obesity drugs, and how co-morbidities factor into development, as well as how it impacts sites and CROs in Phase I through III trials.

Others in the Series

Diabetes Resources

Associations and Societies

Clinical Trials

Obesity Resources

Articles, Multimedia

Associations and Societies

Clinical Trials